Amalgamated Bank’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,559
Closed -$394K 2963
2022
Q4
$394K Buy
23,559
+263
+1% +$4.44K ﹤0.01% 1572
2022
Q3
$400K Buy
23,296
+458
+2% +$7.19K ﹤0.01% 1540
2022
Q2
$179K Buy
22,838
+3,825
+20% +$32.9K ﹤0.01% 1923
2022
Q1
$211K Sell
19,013
-1,566
-8% -$17.5K ﹤0.01% 1919
2021
Q4
$362K Sell
20,579
-164
-0.8% -$3.18K ﹤0.01% 1732
2021
Q3
$420K Sell
20,743
-1,276
-6% -$32.8K ﹤0.01% 1676
2021
Q2
$728K Buy
22,019
+10,826
+97% +$409K 0.01% 1441
2021
Q1
$437K Sell
11,193
-1,093
-9% -$51.3K 0.02% 1058
2020
Q4
$536K Buy
12,286
+59
+0.5% +$2.02K 0.02% 928
2020
Q3
$347K Buy
+12,227
New +$386K 0.02% 1035

Amalgamated Bank's ONEM Position: Q1 2023 in Review

Amalgamated Bank sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 23,559 shares — an estimated $394K sold.

Amalgamated Bank first reported a position in ONEM in Q3 2020 and held it in 10 quarters. The position peaked at $728K in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Amalgamated Bank reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Amalgamated Bank sold 23,559 1Life Healthcare shares in Q1 2023, an estimated $394K.
  • Amalgamated Bank first reported a position in 1Life Healthcare in Q3 2020 and held it in 10 quarters.
  • Amalgamated Bank's 1Life Healthcare position peaked at $728K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Amalgamated Bank's 13F filing for Q1 2023, filed 2 May 2023.